当前位置: 首页 > 期刊 > 《医学信息》 > 202011
编号:13495039
osa-miR168a-5p靶向调节人源ADD1及E2F2基因表达的研究(4)
http://www.100md.com 2020年3月19日 《医学信息》 202011
     [12]Zhang JR,Hu WN,Li CY.A Review of the Epidemiological Evidence for Adducin Family Gene Polymorphisms and Hypertension[J].Cardiol Res Pract,2019(2019):7135604.

    [13]Zhang LN,Liu PP,Wang L,et al.Lower ADD1 gene promoter DNA methylation increases the risk of essential hypertension[J].PLoS One,2013,8(5):e63455.

    [14]Infante A,Laresgoiti U,Fernandez-Rueda J,et al.E2F2 represses cell cycle regulators to maintain quiescence[J].Cell Cycle,2008,7(24):3915-3927.

    [15]Muller H,Bracken AP,Vernell R,et al.E2Fs regulate the expression of genes involved in differentiation,development,proliferation,and apoptosis[J].Genes Dev,2001,15(3):267-285.

    [16]Zhou J,Zhu Y,Cheng M,et al.Regulation of vascular contractility and blood pressure by the E2F2 transcription factor[J].Circulation,2009,120(13):1213-1221.

    [17]Li H,Li Q,Zhang Y,et al.Novel Treatment of Hypertension by Specifically Targeting E2F for Restoration of Endothelial Dihydrofolate Reductase and eNOS Function Under Oxidative Stress[J].Hypertension,2019,73(1):179-189.

    收稿日期:2020-05-12;修回日期:2020-05-22

    編辑/杜帆, 百拇医药(陈真真 蔡军)
上一页1 2 3 4